Home > Insider Trading > Filing (0001209191-15-074305)

Filing Details

Accession Number:: 0001209191-15-074305
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-10-06 15:13:11
Reporting Period:: 2015-10-05

Filing Date:: 2015-10-06
Accepted Time:: 2015-10-06 15:13:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527599	Mirna Therapeutics Inc.	MIRN	Pharmaceutical Preparations (2834)	261824804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1544328	New Enterprise Associates 14, L.p.	1954 Greenspring Drive Suite 600 Timonium MD 21093		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-10-05	1,241,650	$0.00	1,241,650	No	4	C	Direct
Common Stock	Acquisiton	2015-10-06	257,516	$0.00	1,499,166	No	4	J	Direct
Common Stock	Acquisiton	2015-10-05	583,559	$0.00	2,082,725	No	4	C	Direct
Common Stock	Acquisiton	2015-10-06	31,650	$0.00	2,114,375	No	4	J	Direct
Common Stock	Acquisiton	2015-10-06	857,142	$7.00	2,971,517	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	J	Direct
No	4	C	Direct
No	4	J	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Preferred Stock	Disposition	2015-10-05	1,241,650	$0.00	1,241,650	$0.00
Common Stock	Series D Preferred Stock	Disposition	2015-10-05	583,559	$0.00	583,559	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Each share of Series C Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
The securities are directly held by New Enterprise Associates 14, L.P. ("NEA 14") and are indirectly held by NEA Partners 14, L.P. ("NEA Partners 14"), the sole general partner of NEA 14, NEA 14 GP, LTD ("NEA 14 LTD"), the sole general partner of NEA Partners 14 and each of the individual directors of NEA 14 LTD (NEA Partners 14, NEA 14 LTD and the individual directors of NEA 14 LTD (collectively, the "Directors") together, the "Indirect Reporting Persons"). The Directors of NEA 14 LTD are M. James Barrett, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Krishna "Kittu" Kolluri, David M. Mott, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan and Harry R. Weller. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 securities in which the Indirect Reporting Persons have no pecuniary interest.
The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series C Preferred Stock of the Company.
Each share of Series D Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series D Preferred Stock of the Company.
Due to a clerical error, the Reporting Person's Form 3 which previously reported the holding of these shares understated the total by one (1) share.
The expiration date is not relevant to the conversion of these securities.